| (INR) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 13.63B | — |
| Operating expense | — | — |
| Net income | 5.18B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
| Period | Total return |
|---|---|
| All-time high | ₹883.45 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in NATCOPHARM.BO would be worth today ›Yes. NATCO Pharma Limited paid 1 dividend over the past 12 months. The most recent was ₹1.50 per share on Aug 20, 2026. The dividend yield is 0.77%.
NATCO Pharma Limited is part of the Healthcare sector.
NATCO Pharma Limited has a market cap of 158.23B INR, based on the latest quote.
NATCO Pharma Limited is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
